3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This clinical trial evaluates the duration of treatment of chest-indrawing pneumonia in
children. Half the children will receive 3 days of amoxicillin dispersible tablets (DT) and
then 2 days of placebo, while the other half will receive 5 days of amoxicillin DT.
Phase:
Phase 4
Details
Lead Sponsor:
Save the Children
Collaborators:
University of North Carolina University of Washington